المؤلفون: Alexander Grunenberg (11049375), Lisa M. Kaiser (5720951), Stephanie Woelfle (11049378), Birgit Schmelzle (11049381), Andreas Viardot (7331615), Peter Möller (152217), Thomas F. E. Barth (9921593), Rainer Muche (369458), Jens Dreyhaupt (159124), Markus Raderer (607022), Barbara Kiesewetter (607015), Christian Buske (3722989)

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Hematology, Virology, Marginal zone lymphoma, PI3K inhibitor, Copanlisib, Rituximab

Relation: https://figshare.com/articles/journal_contribution/Additional_file_2_of_A_phase_II_study_of_the_PI3K_inhibitor_copanlisib_in_combination_with_the_anti-CD20_monoclonal_antibody_rituximab_for_patients_with_marginal_zone_lymphoma_treatment_rationale_and_protocol_design_of_the_COUP-1_trial/14880735

الاتاحة: https://doi.org/10.6084/m9.figshare.14880735.v1

المؤلفون: Alexander Grunenberg (11049375), Lisa M. Kaiser (5720951), Stephanie Woelfle (11049378), Birgit Schmelzle (11049381), Andreas Viardot (7331615), Peter Möller (152217), Thomas F. E. Barth (9921593), Rainer Muche (369458), Jens Dreyhaupt (159124), Markus Raderer (607022), Barbara Kiesewetter (607015), Christian Buske (3722989)

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Hematology, Virology, Marginal zone lymphoma, PI3K inhibitor, Copanlisib, Rituximab

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_phase_II_study_of_the_PI3K_inhibitor_copanlisib_in_combination_with_the_anti-CD20_monoclonal_antibody_rituximab_for_patients_with_marginal_zone_lymphoma_treatment_rationale_and_protocol_design_of_the_COUP-1_trial/14880732

الاتاحة: https://doi.org/10.6084/m9.figshare.14880732.v1